Filing Details
- Accession Number:
- 0001708138-18-000007
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-05-25 16:03:32
- Reporting Period:
- 2018-05-23
- Accepted Time:
- 2018-05-25 16:03:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 872589 | Regeneron Pharmaceuticals Inc | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1226689 | Neil Stahl | 777 Old Saw Mill River Road Tarrytown NY 10591 | Evp Research And Development | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-05-23 | 26,736 | $30.63 | 58,709 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-05-23 | 15,329 | $293.68 | 43,380 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2018-05-24 | 11,407 | $295.09 | 31,973 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2018-05-23 | 26,736 | $0.00 | 26,736 | $30.63 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2020-12-14 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 4,660 | Indirect | by GRAT |
| Common Stock | 2,317 | Indirect | by GRAT |
| Common Stock | 5,673 | Indirect | By 401(k) Plan |
Footnotes
- Represents volume-weighted average price of sales of 11,407 shares of Company stock on May 24, 2018 at prices ranging from $295.00 to $295.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 24, 2018 at each separate price.
- The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.
Billionaire Hedge Funds
